EXHIBIT 5.1
Opinion of Holland & Knight LLP regarding legality of the Common Stock.

100 North Tampa Street, Suite 4100 | Tampa, FL 33602 | T 813.227.8500 | F 813.229.0134
Holland & Knight LLP | www.hklaw.com
March 11, 2019
RTI Surgical Holdings, Inc.
11621 Research Circle
Alachua, Florida 32615
| Re: | Post-Effective Amendment No. 1 to Registration Statements on FormS-8 |
Ladies and Gentlemen:
We refer to the Post-Effective Amendment No. 1 (the “Amendment”) to registration statements on FormS-8 (File Nos.333-128232,333-149418,333-166543,333-203861,333-217702, and333-224903, collectively, the “Registration Statements”, previously filed by RTI Surgical, Inc., a Delaware corporation (“Old RTI”)), filed today by RTI Surgical Holdings, Inc., a Delaware corporation (the “Company”), with the Securities and Exchange Commission for the purpose of updating the Registration Statements. Pursuant to the Amendment, the Company, as successor to Old RTI, expressly adopts the Registration Statements as its own registration statements for all purposes of the Securities Act of 1933, as amended, and the Securities Exchange Act of 1934, as amended.
As a result of, and in connection with, a holding company reorganization, the Company has assumed from Old RTI the: (i) Regeneration Technologies, Inc. 2004 Equity Incentive Plan; (ii) Tutogen Medical, Inc. 2006 Incentive andNon-Statutory Stock Option Plan; (iii) RTI Biologics, Inc. 2010 Equity Incentive Plan; (iv) RTI Surgical, Inc. 2015 Incentive Compensation Plan; (v) Inducement Restricted Stock Awards and Stock Option Grant to Camille Farhat; and (vi) RTI Surgical, Inc. 2018 Incentive Compensation Plan (collectively, the “Plans”), and all of the outstanding options and equity awards of the Plans. Upon the completion of the holding company reorganization, each outstanding restricted stock award and option to purchase shares of Old RTI common stock was converted into a restricted stock award or option to purchase the same number of shares of the Company’s common stock, with no changes in the option exercise price or other terms and conditions of such options.
In rendering the opinion set forth below, we have acted as counsel for the Company and have examined originals, or copies certified to our satisfaction, of: (i) the Amendment; (ii) the Amended and Restated Certificate of Incorporation of the Company, as amended to date and currently in effect; (iii) the Bylaws of the Company, as amended to date and currently in effect; (iv) the Plans; and (v) certain resolutions of the Board of Directors of the Company adopted in connection with the Amendment. We also examined originals, or copies certified to our satisfaction, of such corporate records of the Company, certificates of public officials, and representatives of the Company, and other documents as we deemed necessary to deliver the opinion expressed below.
In such examination, we have assumed: (i) the authenticity of original documents and the genuineness of all signatures; (ii) the conformity to the originals of all documents submitted to us as copies; (iii) the truth, accuracy, and completeness of the information, representations, and warranties contained in the records, documents, instruments, and certificates we have reviewed; (iv) that there has been no undisclosed waiver of any right, remedy or provision contained in any such documents; and (v) that each transaction complies with all tests of good faith, fairness and conscionability required by law.